<SEC-DOCUMENT>0001136261-20-000007-index.html : 20200103
<SEC-HEADER>0001136261-20-000007.hdr.sgml : 20200103
<ACCEPTANCE-DATETIME>20200103163333
ACCESSION NUMBER:		0001136261-20-000007
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200102
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200103
DATE AS OF CHANGE:		20200103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SEELOS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001017491
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870449967
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22245
		FILM NUMBER:		20506013

	BUSINESS ADDRESS:	
		STREET 1:		300 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		(646) 998-6475

	MAIL ADDRESS:	
		STREET 1:		300 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	APRICUS BIOSCIENCES, INC.
		DATE OF NAME CHANGE:	20100914

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEXMED INC
		DATE OF NAME CHANGE:	19970311
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>body8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: body8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exh5-1.htm
<DESCRIPTION>OPINION
<TEXT>
Document 2 - file: exh5-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>exh10-1.htm
<DESCRIPTION>STOCK PURCHASE AGREEMENT, DATED AS OF JANUARY 2, 2020, BY AND BETWEEN SEELOS THERAPEUTICS, INC. AND PHOENIXUS AG.
<TEXT>
Document 3 - file: exh10-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image4055.jpg
<DESCRIPTION>LOGO
<TEXT>
Document 4 - file: image4055.jpg

</DOCUMENT>
</SEC-DOCUMENT>